Anavex Life Sciences Corp (AVXL)

[nidan7500]

Thanks for this...astounding to me that this point is passed over so casually.

This is one we have covered before on quite a few occasions. It’s also one that, across the period, has taken a bit of a beating in mainstream financial news media. The mechanism of action of its lead candidate has the potential to render what amounts to billions of dollars of Alzheimer’s research wasted and wider market forces seem not to want the asset to successfully reach commercialization.

Then the article (which is nominally well done IMO) continues with a conventional set of timelines based on existing/historical practices and trials schedules. No mention of "what if's" around new MOA. We all here recognize the potential and it is not business as usual in the A2-73 world.

What is going to have to happen to reset the thinking? If the new MOA constitutes BTD not only for AD but multiple CNS indications? This whole thing is either a one or a zero and we will know in less than 6 months.